The Role of Autophagy in Heart Disease

Review The Role of Autophagy in Heart Disease Osman Mohiuddin 1, Sabu Abraham 1, Hongyuan Zhang 1, and Andrea Ruiz-Velasco 2,* 1 The School of Medical Sciences, The University of Manchester, Oxford Road, Manchester M13 9PT, UK 2 Paris Centre de Recherche Cardiovasculaire, INSERM, 56 Rue Leblanc, 75015 Paris, France * Correspondence: [email protected] Received: 21 June 2024; Revised: 15 July 2024; Accepted: 16 July 2024; Published: 19 November 2024 Abstract: Autophagy is an important biological process occurring in eukaryotic cells. There are different forms of autophagy all of which are specialised for their specific roles. The primary role of autophagy is protein degradation, regulating immune responses and maintaining cellular homeostasis. Due to its complexity, autophagy is modulated by many genes and signalling pathways. Autophagy can be induced via different mechanisms, particularly due to oxidative stress and inflammation resulting in lipid peroxidation products and the generation of cytokines. Dysregulation of autophagy modulation pathways can cause different cardiovascular pathologies ranging from atherosclerosis, cardiac hypertrophy, and failure. Targeting autophagy through therapeutic agents has proven to be fruitful in the treatment of diseases. Potential therapies comprising of Rapamycin, an mTOR inhibitor, and Resveratrol, a polyphenol, have both demonstrated efficacy in reversing cardiac hypertrophy through the modulation of autophagy. However, the challenge lies in translating the studies into real therapies which can be used clinically. It is vital to ensure that the effects of Rapamycin and Resveratrol are safe long-term. Perhaps this can be achieved through further understanding autophagy’s complex interaction with other cellular processes. This literature review will explore the different types of autophagy and their role in normal heart physiology. It also aims to study its relation to the heart diseases mentioned above. Lastly, using autophagy as a tool in disease management will also be discussed.

Authors

Publication Details

Journal
International Journal of Drug Discovery and Pharmacology
Published
2024-11-19
DOI
https://doi.org/10.53941/ijddp.2024.100021
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of Autophagy in Heart Disease

Andrea Ruiz‐Velasco, Sabu Abraham, Hongyuan Zhang, Osman Mohiuddin
International Journal of Drug Discovery and Pharmacology
Autophagy in Disease and Therapy
article

The Role of Autophagy in Heart Disease

Andrea Ruiz‐Velasco, Sabu Abraham, Hongyuan Zhang, Osman Mohiuddin
article en

Abstract

Review The Role of Autophagy in Heart Disease Osman Mohiuddin 1, Sabu Abraham 1, Hongyuan Zhang 1, and Andrea Ruiz-Velasco 2,* 1 The School of Medical Sciences, The University of Manchester, Oxford Road, Manchester M13 9PT, UK 2 Paris Centre de Recherche Cardiovasculaire, INSERM, 56 Rue Leblanc, 75015 Paris, France * Correspondence: [email protected] Received: 21 June 2024; Revised: 15 July 2024; Accepted: 16 July 2024; Published: 19 November 2024 Abstract: Autophagy is an important biological process occurring in eukaryotic cells. There are different forms of autophagy all of which are specialised for their specific roles. The primary role of autophagy is protein degradation, regulating immune responses and maintaining cellular homeostasis. Due to its complexity, autophagy is modulated by many genes and signalling pathways. Autophagy can be induced via different mechanisms, particularly due to oxidative stress and inflammation resulting in lipid peroxidation products and the generation of cytokines. Dysregulation of autophagy modulation pathways can cause different cardiovascular pathologies ranging from atherosclerosis, cardiac hypertrophy, and failure. Targeting autophagy through therapeutic agents has proven to be fruitful in the treatment of diseases. Potential therapies comprising of Rapamycin, an mTOR inhibitor, and Resveratrol, a polyphenol, have both demonstrated efficacy in reversing cardiac hypertrophy through the modulation of autophagy. However, the challenge lies in translating the studies into real therapies which can be used clinically. It is vital to ensure that the effects of Rapamycin and Resveratrol are safe long-term. Perhaps this can be achieved through further understanding autophagy’s complex interaction with other cellular processes. This literature review will explore the different types of autophagy and their role in normal heart physiology. It also aims to study its relation to the heart diseases mentioned above. Lastly, using autophagy as a tool in disease management will also be discussed.

International Journal of Drug Discovery and Pharmacology
Good health and well-being
Openalex Percentile: Top 67%
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Role of Autophagy in Heart Disease — Andrea Ruiz‐Velasco, Sabu Abraham, et al. · International Journal of Drug Discovery and Pharmacology (2024) | TGRS Research Map | TGRS